ContractTrial and Option Agreement • November 10th, 2014 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 10th, 2014 Company IndustryConfidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 of the Exchange Act of 1934, as amended. Confidential Portions are marked: [***].
SECOND AMENDMENT TO CLINICAL TRIAL AND OPTION AGREEMENTTrial and Option Agreement • August 6th, 2020 • Lineage Cell Therapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 6th, 2020 Company IndustryCANCER RESEARCH UK a company limited by guarantee registered under number 4325234 and a charity registered under number 1089464 of 2 Redman Place, Stratford, London, E20 1JQ, England (the “Charity”);